Kineta, Inc./De financial data

Symbol
KANT on OTC
Industry
Pharmaceutical Preparations
Location
7683 Se 27 Th Street, Suite 481, Mercer Island, WA
State of incorporation
DE
Fiscal year end
December 31
Former names
YUMANITY THERAPEUTICS, INC. (to 12/16/2022), PROTEOSTASIS THERAPEUTICS, INC. (to 12/16/2020), PROTEOSTASIS THERAPEUTICS INC (to 6/2/2011)
Latest financial report
10-Q - Q3 2024 - Nov 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 31.8 % -70.8%
Debt-to-equity -173 % -157%
Return On Equity 334 %
Return On Assets -423 % -6.31%
Operating Margin -303 % +87.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 12.3M shares +18%
Common Stock, Shares, Outstanding 12.3M shares +20.1%
Entity Public Float 10.3M USD -43.1%
Common Stock, Value, Issued 12K USD +20%
Weighted Average Number of Shares Outstanding, Basic 13.4M shares +14.6%
Weighted Average Number of Shares Outstanding, Diluted 13.4M shares +14.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 0 USD -100%
Revenue from Contract with Customer, Excluding Assessed Tax 0 USD
Research and Development Expense 6.19M USD -52%
General and Administrative Expense 9.13M USD -27.8%
Operating Income (Loss) -15.3M USD +60.2%
Nonoperating Income (Expense) -1.98M USD +90.1%
Net Income (Loss) Attributable to Parent -17.3M USD +70.4%
Earnings Per Share, Basic -1.31 USD/shares +87.7%
Earnings Per Share, Diluted -1.31 USD/shares +87.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 8.42M USD -80.7%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD
Assets, Current 2.22M USD -71.7%
Property, Plant and Equipment, Net 0 USD -100%
Operating Lease, Right-of-Use Asset 0 USD -100%
Assets 2.22M USD -79.3%
Accounts Payable, Current 4.84M USD +11.6%
Employee-related Liabilities, Current 534K USD
Accrued Liabilities, Current 1.23M USD -34%
Liabilities, Current 11.8M USD +54.5%
Operating Lease, Liability, Noncurrent 0 USD -100%
Liabilities 11.8M USD +50.6%
Retained Earnings (Accumulated Deficit) -180M USD -10.6%
Stockholders' Equity Attributable to Parent -9.71M USD -458%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -9.55M USD -431%
Liabilities and Equity 2.22M USD -79.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4.01M USD +18.8%
Net Cash Provided by (Used in) Financing Activities 750K USD
Net Cash Provided by (Used in) Investing Activities 0 USD -100%
Common Stock, Shares Authorized 125M shares 0%
Common Stock, Shares, Issued 12.3M shares +20.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -4.01M USD -2.69%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.95M USD -74.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 5K USD -61.5%
Deferred Tax Assets, Valuation Allowance 175M USD +1.16%
Deferred Tax Assets, Gross 175M USD +1.1%
Operating Lease, Liability 81K USD -91.7%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -32M USD +51.3%
Lessee, Operating Lease, Liability, to be Paid 796K USD
Property, Plant and Equipment, Gross 0 USD -100%
Operating Lease, Liability, Current 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year Two 561K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 81K USD -82.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year Three 0 USD -100%
Deferred Tax Assets, Operating Loss Carryforwards 145M USD +0.35%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares
Unrecognized Tax Benefits 1M USD +20.8%
Lessee, Operating Lease, Liability, to be Paid, Year Four 0 USD -100%
Operating Lease, Payments 715K USD -23.1%
Additional Paid in Capital 171M USD +2.93%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 0 USD -100%
Deferred Tax Assets, Net of Valuation Allowance 115K USD -46%
Share-based Payment Arrangement, Expense 1.51M USD -79.8%
Interest Expense 367K USD -86.1%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares